Myopathy: Five New Things
- Risk of statin toxicity increases along with increases in their lipophilicity, cholesterol-lowering potency, and dosage.
- In immune-mediated statin myopathy, discontinuation does not translate into immediate recovery.
- MRI and muscle ultrasound in myopathy may provide detailed anatomic information.
- Autoantibody testing may be helpful in defining myopathies of unclear cause.
- Enzyme replacement may improve function in Pompe disease.